Literature DB >> 31994145

Acute Vestibular Syndrome.

Kevin A Kerber1.   

Abstract

The acute vestibular syndrome (AVS) is a label for presentations of new-onset severe dizziness, vertigo, or imbalance, with examination findings of nystagmus or gait unsteadiness. The prototypical AVS presentation is the acute unilateral vestibulopathy due to vestibular neuritis. Stroke is also a serious concern in patients with AVS. Most other peripheral vestibular disorders present as episodic or chronic syndromes. In this article, the diagnostic considerations, exam findings, and management of AVS are reviewed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2020        PMID: 31994145     DOI: 10.1055/s-0039-3402739

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  5 in total

1.  Concurrent brain structural and functional alterations in patients with chronic unilateral vestibulopathy.

Authors:  Lihong Si; Bin Cui; Zheyuan Li; Xiang Li; Kangzhi Li; Xia Ling; Bo Shen; Xu Yang
Journal:  Quant Imaging Med Surg       Date:  2022-06

2.  Long-Term Evolution of Vestibular Compensation, Postural Control, and Perceived Disability in a Population of Patients with Vestibular Neuritis.

Authors:  Jonathan Esteban-Sanchez; Eduardo Martin-Sanz
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

3.  The Spectrum of Vestibular Disorders Presenting With Acute Continuous Vertigo.

Authors:  Qingxiu Yao; Zhuangzhuang Li; Maoxiang Xu; Yumeng Jiang; Jingjing Wang; Hui Wang; Dongzhen Yu; Shankai Yin
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

4.  Positive horizontal-canal head impulse test is not a benign sign for acute vestibular syndrome with hearing loss.

Authors:  Anand K Bery; Tzu-Pu Chang
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

Review 5.  Current Insights into Treating Vertigo in Older Adults.

Authors:  Augusto Pietro Casani; Mauro Gufoni; Silvia Capobianco
Journal:  Drugs Aging       Date:  2021-06-23       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.